Ayala Pharmaceuticals Inc (STU:FAD)
€ 0.01 -0.04 (-80%) Market Cap: 788,000.00 Enterprise Value: 3.88 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

Q2 2020 Advaxis Inc Earnings Call Transcript

Jun 11, 2020 / 03:00PM GMT
Operator

Greetings, and welcome to the Advaxis, Inc. conference call to discuss second quarter 2020 financial results and business updates. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Tim McCarthy of LifeSci Advisors. Thank you, sir. You may begin.

Timothy McCarthy
LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, Michelle, and thank you, everyone, for joining us for today's conference call to discuss Advaxis' Second Quarter 2020 Financial Results and Business Update. If you have not seen today's press release, please visit Advaxis' website at www.advaxis.com.

Before turning the call over to Ken Berlin, Advaxis' President and Chief Executive Officer, I would like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. Any statements that are not historical fact, including, but not limited to, statements that contain words

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot